RecruitingNot ApplicableNCT07060066

Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia


Sponsor

The University of Texas Health Science Center, Houston

Enrollment

120 participants

Start Date

May 21, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to provide an effective repetitive transcranial magnetic stimulation (rTMS) treatment for depressive symptoms in patients with schizophrenia. Schizophrenia patients with depressive symptoms will be exposed to rTMS to improve their symptoms.


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a specialized form of brain stimulation called transcranial magnetic stimulation (TMS) — delivered to two regions of the brain (the prefrontal cortex and the insula) — to treat depression in people with schizophrenia-spectrum disorders. TMS is a non-invasive procedure using magnetic pulses applied to the scalp. **You may be eligible if...** - You are between 18 and 60 years of age - You have been diagnosed with a schizophrenia-spectrum disorder - You score above a threshold on the Calgary Depression Scale for Schizophrenia, indicating significant depressive symptoms - You are able to provide written informed consent and understand the study **You may NOT be eligible if...** - You have metal implants in your head or a pacemaker (TMS safety concern) - You have a history of seizures or epilepsy - You have major medical illnesses that could affect brain stimulation safety - You are currently in an acute psychotic episode that prevents participation - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEActive rTMS stimulation

Active H-coil delivered rTMS sessions will be given three times per treatment visit for up to 20 visits for about 4 weeks. There are about 30 minutes breaks between adjacent TMS sessions. Each TMS session takes about 3 to 4 minutes to complete.

DEVICESham rTMS stimulation

Sham H-coil delivered rTMS sessions will be given three times per treatment visit for up to 20 visits for about 4 weeks. There are about 30 minutes breaks between adjacent TMS sessions. Each TMS session takes about 3 to 4 minutes to complete.


Locations(1)

The University of Texas Health Science Center at Houston

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07060066


Related Trials